InsuTAG: A novel physiologically relevant predictor for insulin resistance and metabolic syndrome

[1]  J. Romijn,et al.  Methods for quantifying adipose tissue insulin resistance in overweight/obese humans , 2017, International Journal of Obesity.

[2]  L. Hsu,et al.  Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals , 2016, PloS one.

[3]  M. Garg,et al.  Sex-dependent association between erythrocyte n-3 PUFA and type 2 diabetes in older overweight people. , 2016, The British journal of nutrition.

[4]  D. Simonson.  Surrogate measures of insulin resistance: does one size fit all? , 2015, Diabetologia.

[5]  Xuefeng Yu,et al.  O R I G I N a L I N V E S T I G a T I O N Open Access , 2022 .

[6]  M. Laakso,et al.  Insulin resistance and hyperglycaemia in cardiovascular disease development , 2014, Nature Reviews Endocrinology.

[7]  Jingyuan Fu,et al.  Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance? , 2014, Atherosclerosis.

[8]  L. Guoping,et al.  Triglyceride-to-HDL cholesterol ratio , 2013, Herz.

[9]  K. Adeli,et al.  Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[10]  L. Gormsen,et al.  Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men , 2011, Diabetes.

[11]  S. Caprio,et al.  The Triglyceride-to-HDL Cholesterol Ratio , 2011, Diabetes Care.

[12]  M. Rodríguez-Moran,et al.  The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. , 2010, The Journal of clinical endocrinology and metabolism.

[13]  Bhawna Singh,et al.  Surrogate markers of insulin resistance: A review. , 2010, World journal of diabetes.

[14]  C. Lassale,et al.  Estimating food intakes in Australia: validation of the Commonwealth Scientific and Industrial Research Organisation (CSIRO) food frequency questionnaire against weighed dietary intakes. , 2009, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[15]  K. Adeli,et al.  Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. , 2009, Clinical biochemistry.

[16]  Richard Kahn,et al.  Relationship of Insulin Resistance and Related Metabolic Variables to Coronary Artery Disease: A Mathematical Analysis , 2009, Diabetes Care.

[17]  P. Nilsson,et al.  Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes , 2007, Journal of Human Hypertension.

[18]  M. Laakso,et al.  Lipids and glucose in type 2 diabetes: what is the cause and effect? , 2004, Diabetes care.

[19]  Tracey McLaughlin,et al.  Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant , 2003, Annals of Internal Medicine.

[20]  H. Kahn,et al.  Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. , 2003, The American journal of clinical nutrition.

[21]  D. Chisholm,et al.  Multiple indexes of lipid availability are independently related to whole body insulin action in healthy humans. , 2003, The Journal of clinical endocrinology and metabolism.

[22]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[23]  M. Laakso,et al.  Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men. , 2001, Diabetes care.

[24]  W. Harris,et al.  n-3 fatty acids and serum lipoproteins: animal studies. , 1997, The American journal of clinical nutrition.

[25]  G. Mingrone,et al.  Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids , 1997, Diabetologia.

[26]  W. Harris,et al.  n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. , 1997, The American journal of clinical nutrition.

[27]  A. Krolewski,et al.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.

[28]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[29]  G. Reaven.  Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[30]  B V Howard,et al.  Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. , 1988, The New England journal of medicine.

[31]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[32]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[33]  M. Garg,et al.  Association between omega-3 index and blood lipids in older Australians. , 2016, The Journal of nutritional biochemistry.

[34]  W. Harris,et al.  n-3 fatty acids and serum lipoproteins: human studies. , 1997, The American journal of clinical nutrition.